Re: Trial Enrollment Difficulties
|
2
|
Mannkind
|
Jul 08, 2012 10:21PM
|
Re: Exubera's ghost
|
2
|
Mannkind
|
Apr 06, 2013 01:32PM
|
Re: Follow the Herd of Bulls Into Small Cap MannKind Corporation (MNKD)?
|
2
|
Mannkind
|
Aug 21, 2012 12:29PM
|
Re: Behold
|
2
|
Mannkind
|
Mar 18, 2013 10:24AM
|
Re: What happened to OPC?
|
2
|
Mannkind
|
Apr 15, 2013 01:17PM
|
Re: To: Sspdx,,,,Your comments are disturbing!
|
2
|
Mannkind
|
Aug 21, 2012 01:20PM
|
Re: New SA Article
|
2
|
Mannkind
|
Jun 27, 2013 05:55PM
|
Re: When the study data is available to MNKD is vital to partnership discussions
|
2
|
Mannkind
|
Oct 06, 2012 11:24AM
|
Re: Old class action suit question?
|
2
|
Mannkind
|
Jun 03, 2013 03:57PM
|
Re: Conference News ???
|
3
|
Mannkind
|
May 24, 2013 11:26AM
|
Re: Technospehere
|
3
|
Mannkind
|
Jun 16, 2013 03:49PM
|
Re: Valuation Based on AMLN Sale
|
3
|
Mannkind
|
Aug 23, 2012 09:13PM
|
Re: U.S. Food and Drug Administration Approved 30% More Drugs in 2012
|
3
|
Mannkind
|
Feb 18, 2013 10:52PM
|
Re: Final 90 days of study.
|
3
|
Mannkind
|
Oct 13, 2012 05:44PM
|
Re: Exubera's ghost
|
3
|
Mannkind
|
Apr 05, 2013 05:15PM
|
Re: Basalin?
|
4
|
Mannkind
|
Aug 15, 2012 01:39PM
|
Re: European Regulator Finds Little Risk in Diabetes Drugs
|
4
|
Mannkind
|
Jul 28, 2013 10:42AM
|
Re: BMY just listed hundreds of new diabetes sales positions
|
4
|
Mannkind
|
Aug 07, 2013 09:52PM
|
Re: Short interest????
|
4
|
Mannkind
|
May 26, 2013 08:01PM
|
Re: Quick update! and we will never see $1.50 again!
|
4
|
Mannkind
|
Sep 21, 2012 02:19PM
|